Folgen
Ervant Maksabedian Hernandez
Ervant Maksabedian Hernandez
Health Economist, BMS
Bestätigte E-Mail-Adresse bei bms.com
Titel
Zitiert von
Zitiert von
Jahr
In the weeds: a baseline view of cannabis use among legalizing states and their neighbours
RL Pacula, M Jacobson, EJ Maksabedian
Addiction 111 (6), 973-980, 2016
1622016
Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: a systematic review
MA Maglione, L Raaen, C Chen, G Azhar, N Shahidinia, M Shen, ...
Journal of substance abuse treatment 89, 28-51, 2018
982018
Enhancing Family Stability During Permanent Change of Station: A Review of Disruptions and Policies
PK Tong, L Payne, C Bond, SO Meadows, JL Lewis, EM Friedman, ...
RAND Corporation, 2018
492018
A computer-assisted motivational social network intervention to reduce alcohol, drug and HIV risk behaviors among Housing First residents
DP Kennedy, SB Hunter, KC Osilla, E Maksabedian, D Golinelli, ...
Addiction science & clinical practice 11, 1-13, 2016
422016
A pilot test of a motivational interviewing social network intervention to reduce substance use among housing first residents
DP Kennedy, KC Osilla, SB Hunter, D Golinelli, EM Hernandez, JS Tucker
Journal of Substance Abuse Treatment 86, 36-44, 2018
392018
Resources and capabilities of the Department of Veterans Affairs to provide timely and accessible care to veterans
PS Hussey, JS Ringel, S Ahluwalia, RA Price, C Buttorff, TW Concannon, ...
Rand Health Quarterly 5 (4), 2016
372016
Feasibility of a computer-assisted social network motivational interviewing intervention for substance use and HIV risk behaviors for housing first residents
KC Osilla, DP Kennedy, SB Hunter, E Maksabedian
Addiction science & clinical practice 11, 1-11, 2016
212016
Psoriatic arthritis treatment patterns and costs among pharmacologic treatment-naïve patients.
MH EJ, J Tkacz, L Lopez-Gonzalez, K Higgins, A Ogdie, BS Stolshek
The American Journal of Managed Care 26 (8), e252-e257, 2020
112020
Effectiveness and costs among rheumatoid arthritis patients treated with targeted immunomodulators using real-world US data
M Gharaibeh, M Bonafede, D McMorrow, EJM Hernandez, BS Stolshek
Journal of Managed Care & Specialty Pharmacy 26 (8), 1039-1049, 2020
102020
Effects of Medication-Assisted Treatment (MAT) for opioid use disorder on functional outcomes: a systematic review
MA Maglione, L Raaen, C Chen, GS Azhar, S Nima, M Shen, ...
Rand Health Quarterly 8 (4), 2020
72020
Side effects of methotrexate and tumor necrosis factor inhibitors: differences in tolerability among patients with psoriatic arthritis and rheumatoid arthritis
A Ogdie, EJ Maksabedian Hernandez, Y Shaw, B Stolshek, K Michaud
ACR Open Rheumatology 4 (11), 935-941, 2022
52022
Restructuring personal networks with a Motivational Interviewing social network intervention to assist the transition out of homelessness: A randomized control pilot study
DP Kennedy, KC Osilla, SB Hunter, D Golinelli, ...
Plos one 17 (1), e0262210, 2022
52022
Estimating the impact of Biosimilar entry on prices and expenditures in rheumatoid arthritis: a case study of targeted immune Modulators
EJ Maksabedian Hernandez, M Graf, A Portelli, J Shafrin
Journal of Medical Economics 25 (1), 1118-1126, 2022
42022
The effect of dose escalation on the cost-effectiveness of etanercept and adalimumab with methotrexate among patients with moderate to severe rheumatoid arthritis
D Incerti, EJM Hernandez, J Tkacz, JP Jansen, D Collier, M Gharaibeh, ...
Journal of Managed Care & Specialty Pharmacy 26 (10), 1236-1242, 2020
42020
Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination
V Strand, PJ Mease, EJM Hernandez, BS Stolshek, LXH Liu, DH Collier, ...
RMD open 7 (1), e001484, 2021
22021
Estimating the costs of substitution therapy for heroin and opioid addiction in the United States: insights and challenges
E Maksabedian, R Liccardo Pacula, B Stein
Drug treatment expenditure: a methodological overview, 143-157, 2017
22017
A motivational interviewing social network intervention to reduce substance use among housing first residents
DP Kennedy, KC Osilla, SB Hunter, D Golinelli, E Maksabedian, ...
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH 42, 292A-292A, 2018
12018
Increasing Access to Medication-Assisted Treatment for Opioid Use Disorders: Estimating Costs, Supply, and the Effects of Insurance Expansions
EJM Hernandez
The Pardee RAND Graduate School, 2017
12017
Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study
A Ogdie, Y Shaw, M Almonte, EJ Maksabedian Hernandez, B Stolshek, ...
ACR Open Rheumatology 5 (4), 167-172, 2023
2023
A conceptual modelling framework for estimating the consequences of psoriatic arthritis disease domains
JW Chou, EJ Maksabedian Hernandez, DH Collier, H Thom
medRxiv, 2021.08. 09.21261799, 2021
2021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20